TreeWAS – Variant ID: rs78737652

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
# Top node	0.992	0.008
Chapter II Neoplasms	0.992	0.008
D37-D48 Neoplasms of uncertain or unknown behaviour	0.982	0.018
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.977	0.023
Chapter I Certain infectious and parasitic diseases	0.969	0.031
D50-D53 Nutritional anaemias	0.963	0.037
Chapter X Diseases of the respiratory system	0.960	0.040
Chapter VII Diseases of the eye and adnexa	0.959	0.041
Chapter XX External causes of morbidity and mortality	0.957	0.043
J30-J39 Other diseases of upper respiratory tract	0.957	0.043
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.941	0.059
B35-B49 Mycoses	0.934	0.066
C60-C63 Malignant neoplasms of male genital organs	0.933	0.067
D50 Iron deficiency anaemia	0.931	0.069
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.922	0.078
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.921	0.079
Chapter VI Diseases of the nervous system	0.918	0.082
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.912	0.088
C15-C26 Malignant neoplasms of digestive organs	0.912	0.088
B37 Candidiasis	0.910	0.090
J38.3 Other diseases of vocal cords	0.907	0.093
B37.0 Candidal stomatitis	0.894	0.106
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.890	0.110
C61 Malignant neoplasm of prostate	0.889	0.111
G40-G47 Episodic and paroxysmal disorders	0.882	0.118
A30-A49 Other bacterial diseases	0.881	0.119
D51 Vitamin B12 deficiency anaemia	0.879	0.121
H30-H36 Disorders of choroid and retina	0.875	0.125
J32 Chronic sinusitis	0.873	0.127
C64-C68 Malignant neoplasms of urinary tract	0.872	0.128
H10-H13 Disorders of conjunctiva	0.870	0.130
C50-C50 Malignant neoplasm of breast	0.869	0.131
D50.9 Iron deficiency anaemia, unspecified	0.867	0.133
D47.2 Monoclonal gammopathy	0.861	0.139
Chapter XIV Diseases of the genitourinary system	0.860	0.140
G20-G26 Extrapyramidal and movement disorders	0.849	0.151
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.849	0.151
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.841	0.159
Chapter IV Endocrine, nutritional and metabolic diseases	0.839	0.161
J09-J18 Influenza and pneumonia	0.832	0.168
Y43 Primarily systemic agents	0.828	0.172
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.818	0.182
C90 Multiple myeloma and malignant plasma cell neoplasms	0.811	0.189
C18 Malignant neoplasm of colon	0.811	0.189
H11 Other disorders of conjunctiva	0.811	0.189
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.807	0.193
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.807	0.193
N20-N23 Urolithiasis	0.806	0.194
E70-E90 Metabolic disorders	0.804	0.196
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.803	0.197
G45 Transient cerebral ischaemic attacks and related syndromes	0.802	0.198
J32.9 Chronic sinusitis, unspecified	0.801	0.199
B25-B34 Other viral diseases	0.801	0.199
D37.5 Rectum	0.799	0.201
G40 Epilepsy	0.797	0.203
A49 Bacterial infection of unspecified site	0.796	0.204
N21 Calculus of lower urinary tract	0.790	0.210
Y52 Agents primarily affecting the cardiovascular system	0.784	0.216
J38.0 Paralysis of vocal cords and larynx	0.784	0.216
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.783	0.217
C50 Malignant neoplasm of breast	0.781	0.219
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.776	0.224
E87 Other disorders of fluid, electrolyte and acid-base balance	0.773	0.227
J38.1 Polyp of vocal cord and larynx	0.772	0.228
N21.0 Calculus in bladder	0.772	0.228
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.769	0.231
B15-B19 Viral hepatitis	0.767	0.232
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.765	0.235
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.765	0.235
Chapter XXII Codes for special purposes	0.762	0.238
D46 Myelodysplastic syndromes	0.762	0.238
D80-D89 Certain disorders involving the immune mechanism	0.761	0.239
C64 Malignant neoplasm of kidney, except renal pelvis	0.761	0.239
J34 Other disorders of nose and nasal sinuses	0.760	0.240
H35 Other retinal disorders	0.756	0.244
C90.0 Multiple myeloma	0.754	0.246
H25-H28 Disorders of lens	0.752	0.248
C19 Malignant neoplasm of rectosigmoid junction	0.752	0.248
G47 Sleep disorders	0.752	0.248
N00-N08 Glomerular diseases	0.750	0.250
J37 Chronic laryngitis and laryngotracheitis	0.750	0.250
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.749	0.251
J60-J70 Lung diseases due to external agents	0.748	0.252
D47.1 Chronic myeloproliferative disease	0.745	0.255
J30 Vasomotor and allergic rhinitis	0.743	0.257
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.742	0.258
G25 Other extrapyramidal and movement disorders	0.741	0.259
C17 Malignant neoplasm of small intestine	0.740	0.260
N70-N77 Inflammatory diseases of female pelvic organs	0.739	0.261
D37.7 Other digestive organs	0.736	0.264
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.736	0.264
G45.9 Transient cerebral ischaemic attack, unspecified	0.734	0.266
G20 Parkinson's disease	0.732	0.268
E87.2 Acidosis	0.732	0.268
Y48 Anaesthetics and therapeutic gases	0.731	0.269
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.731	0.269
C26 Malignant neoplasm of other and ill-defined digestive organs	0.726	0.274
C50.4 Upper-outer quadrant of breast	0.723	0.277
Y43.3 Other antineoplastic drugs	0.722	0.278
W20-W49 Exposure to inanimate mechanical forces	0.716	0.283
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.715	0.284
B90-B94 Sequelae of infectious and parasitic diseases	0.715	0.285
C51-C58 Malignant neoplasms of female genital organs	0.714	0.286
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.713	0.287
Chapter XVI Certain conditions originating in the perinatal period	0.711	0.289
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.711	0.289
C40-C41 Malignant neoplasms of bone and articular cartilage	0.711	0.289
V80-V89 Other land transport accidents	0.710	0.290
G40.9 Epilepsy, unspecified	0.710	0.290
D37.1 Stomach	0.709	0.291
E86 Volume depletion	0.706	0.294
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.706	0.294
H55-H59 Other disorders of eye and adnexa	0.705	0.295
D00-D09 In situ neoplasms	0.705	0.295
H11.8 Other specified disorders of conjunctiva	0.704	0.296
V10-V19 Pedal cyclist injured in transport accident	0.704	0.296
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.704	0.296
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.704	0.296
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.704	0.296
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.704	0.296
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.704	0.296
J18 Pneumonia, organism unspecified	0.703	0.297
J38.4 Oedema of larynx	0.701	0.299
D37.4 Colon	0.701	0.299
N72 Inflammatory disease of cervix uteri	0.700	0.300
D55-D59 Haemolytic anaemias	0.700	0.300
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.700	0.300
X40-X49 Accidental poisoning by and exposure to noxious substances	0.700	0.300
J31.0 Chronic rhinitis	0.699	0.301
A41 Other septicaemia	0.699	0.301
H34 Retinal vascular occlusions	0.698	0.302
W00-W19 Falls	0.697	0.303
B99-B99 Other infectious diseases	0.695	0.305
B85-B89 Pediculosis, acariasis and other infestations	0.695	0.305
B65-B83 Helminthiases	0.695	0.305
B50-B64 Protozoal diseases	0.695	0.305
B20-B24 Human immunodeficiency virus [HIV] disease	0.695	0.305
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.695	0.305
A80-A89 Viral infections of the central nervous system	0.695	0.305
A75-A79 Rickettsioses	0.695	0.305
A70-A74 Other diseases caused by chlamydiae	0.695	0.305
A65-A69 Other spirochaetal diseases	0.695	0.305
A20-A28 Certain zoonotic bacterial diseases	0.695	0.305
A15-A19 Tuberculosis	0.695	0.305
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.694	0.306
D45 Polycythaemia vera	0.694	0.306
C21 Malignant neoplasm of anus and anal canal	0.694	0.306
B37.8 Candidiasis of other sites	0.693	0.306
N30-N39 Other diseases of urinary system	0.692	0.308
H36 Retinal disorders in diseases classified elsewhere	0.692	0.308
D53 Other nutritional anaemias	0.690	0.309
D52 Folate deficiency anaemia	0.690	0.309
D70-D77 Other diseases of blood and blood-forming organs	0.690	0.310
J38.7 Other diseases of larynx	0.690	0.310
C16 Malignant neoplasm of stomach	0.689	0.311
C18.2 Ascending colon	0.688	0.311
H46-H48 Disorders of optic nerve and visual pathways	0.688	0.312
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.687	0.313
V20-V29 Motorcycle rider injured in transport accident	0.686	0.314
Y35-Y36 Legal intervention and operations of war	0.686	0.314
Y10-Y34 Event of undetermined intent	0.686	0.314
Y00-Y09 Assault	0.686	0.314
X85-X99 Assault	0.686	0.314
X58-X59 Accidental exposure to other and unspecified factors	0.686	0.314
X50-X57 Overexertion, travel and privation	0.686	0.314
X30-X39 Exposure to forces of nature	0.686	0.314
X20-X29 Contact with venomous animals and plants	0.686	0.314
X10-X19 Contact with heat and hot substances	0.686	0.314
X00-X09 Exposure to smoke, fire and flames	0.686	0.314
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.686	0.314
W75-W84 Other accidental threats to breathing	0.686	0.314
W65-W74 Accidental drowning and submersion	0.686	0.314
W50-W64 Exposure to animate mechanical forces	0.686	0.314
V98-V99 Other and unspecified transport accidents	0.686	0.314
V95-V97 Air and space transport accidents	0.686	0.314
V90-V94 Water transport accidents	0.686	0.314
V70-V79 Bus occupant injured in transport accident	0.686	0.314
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.686	0.314
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.686	0.314
V40-V49 Car occupant injured in transport accident	0.686	0.314
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.686	0.314
V01-V09 Pedestrian injured in transport accident	0.686	0.314
C66 Malignant neoplasm of ureter	0.684	0.316
E87.1 Hypo-osmolality and hyponatraemia	0.684	0.316
G47.3 Sleep apnoea	0.684	0.316
D48.6 Breast	0.683	0.317
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.681	0.319
C18.4 Transverse colon	0.680	0.319
G90-G99 Other disorders of the nervous system	0.679	0.321
Y43.1 Antineoplastic antimetabolites	0.678	0.322
H11.4 Other conjunctival vascular disorders and cysts	0.676	0.323
C62 Malignant neoplasm of testis	0.676	0.324
C15 Malignant neoplasm of oesophagus	0.676	0.324
J38.6 Stenosis of larynx	0.675	0.325
J38.5 Laryngeal spasm	0.675	0.325
J38.2 Nodules of vocal cords	0.675	0.325
A50-A64 Infections with a predominantly sexual mode of transmission	0.673	0.327
B35 Dermatophytosis	0.671	0.328
J80-J84 Other respiratory diseases principally affecting the interstitium	0.671	0.329
B48 Other mycoses, not elsewhere classified	0.670	0.330
B47 Mycetoma	0.670	0.330
B46 Zygomycosis	0.670	0.330
B45 Cryptococcosis	0.670	0.330
B44 Aspergillosis	0.670	0.330
B43 Chromomycosis and phaeomycotic abscess	0.670	0.330
B42 Sporotrichosis	0.670	0.330
B41 Paracoccidioidomycosis	0.670	0.330
B40 Blastomycosis	0.670	0.330
B39 Histoplasmosis	0.670	0.330
B38 Coccidioidomycosis	0.670	0.330
B36 Other superficial mycoses	0.670	0.330
B49 Unspecified mycosis	0.670	0.330
A49.0 Staphylococcal infection, unspecified	0.670	0.330
J15 Bacterial pneumonia, not elsewhere classified	0.669	0.330
C63 Malignant neoplasm of other and unspecified male genital organs	0.669	0.331
C60 Malignant neoplasm of penis	0.669	0.331
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.669	0.331
Q38-Q45 Other congenital malformations of the digestive system	0.668	0.332
H18 Other disorders of cornea	0.668	0.332
D50.1 Sideropenic dysphagia	0.667	0.332
D60-D64 Aplastic and other anaemias	0.667	0.333
C50.1 Central portion of breast	0.665	0.335
B34 Viral infection of unspecified site	0.665	0.335
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.664	0.336
Y44 Agents primarily affecting blood constituents	0.662	0.338
Y59 Other and unspecified vaccines and biological substances	0.661	0.339
Y58 Bacterial vaccines	0.661	0.339
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.661	0.339
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.661	0.339
Y53 Agents primarily affecting the gastro-intestinal system	0.661	0.339
Y50 Central nervous system stimulants, not elsewhere classified	0.661	0.339
Y49 Psychotropic drugs, not elsewhere classified	0.661	0.339
Y47 Sedatives, hypnotics and antianxiety drugs	0.661	0.339
Y46 Antiepileptics and anti-Parkinsonism drugs	0.661	0.339
Y41 Other systemic anti-infectives and antiparasitics	0.661	0.339
Q50-Q56 Congenital malformations of genital organs	0.661	0.339
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.660	0.339
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.660	0.339
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.660	0.339
D47.4 Osteomyelofibrosis	0.660	0.339
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.660	0.339
C18.3 Hepatic flexure	0.660	0.340
G00-G09 Inflammatory diseases of the central nervous system	0.658	0.342
J32.4 Chronic pansinusitis	0.658	0.342
Y40 Systemic antibiotics	0.658	0.342
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.657	0.343
N99-N99 Other disorders of the genitourinary system	0.656	0.344
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.656	0.344
X60-X84 Intentional self-harm	0.655	0.345
N17-N19 Renal failure	0.655	0.345
J18.0 Bronchopneumonia, unspecified	0.655	0.345
D37.9 Digestive organ, unspecified	0.654	0.346
D37.6 Liver, gallbladder and bile ducts	0.654	0.346
D37.3 Appendix	0.654	0.346
D37.2 Small intestine	0.654	0.346
D37.0 Lip, oral cavity and pharynx	0.654	0.346
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.654	0.346
C23 Malignant neoplasm of gallbladder	0.654	0.346
B37.7 Candidal septicaemia	0.652	0.348
B37.6 Candidal endocarditis	0.652	0.348
B37.5 Candidal meningitis	0.652	0.348
B37.4 Candidiasis of other urogenital sites	0.652	0.348
B37.2 Candidiasis of skin and nail	0.652	0.348
B37.1 Pulmonary candidiasis	0.652	0.348
H21 Other disorders of iris and ciliary body	0.652	0.348
D50.8 Other iron deficiency anaemias	0.652	0.348
J35 Chronic diseases of tonsils and adenoids	0.652	0.348
Y84.0 Cardiac catheterisation	0.649	0.351
Y51 Drugs primarily affecting the autonomic nervous system	0.647	0.353
N21.1 Calculus in urethra	0.647	0.353
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.647	0.353
H43-H45 Disorders of vitreous body and globe	0.646	0.354
C81 Hodgkin's disease	0.646	0.354
Q60-Q64 Congenital malformations of the urinary system	0.645	0.355
C50.5 Lower-outer quadrant of breast	0.644	0.355
Y57 Other and unspecified drugs and medicaments	0.644	0.356
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.644	0.356
D47.3 Essential (haemorrhagic) thrombocythaemia	0.644	0.356
A49.9 Bacterial infection, unspecified	0.644	0.356
G70-G73 Diseases of myoneural junction and muscle	0.644	0.356
C92 Myeloid leukaemia	0.643	0.357
G25.0 Essential tremor	0.642	0.358
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.642	0.358
Y60-Y69 Misadventures to patients during surgical and medical care	0.642	0.358
E80 Disorders of porphyrin and bilirubin metabolism	0.641	0.359
Q80-Q89 Other congenital malformations	0.640	0.360
H33 Retinal detachments and breaks	0.639	0.360
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.638	0.361
C95 Leukaemia of unspecified cell type	0.638	0.361
C94 Other leukaemias of specified cell type	0.638	0.361
C93 Monocytic leukaemia	0.638	0.361
C88 Malignant immunoproliferative diseases	0.638	0.361
C86 Other specified types of T/NK-cell lymphoma	0.638	0.361
C84 Peripheral and cutaneous T-cell lymphomas	0.638	0.361
H50 Other strabismus	0.638	0.362
J20-J22 Other acute lower respiratory infections	0.638	0.362
E73 Lactose intolerance	0.635	0.365
J32.0 Chronic maxillary sinusitis	0.635	0.365
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.634	0.366
H26 Other cataract	0.634	0.366
A49.8 Other bacterial infections of unspecified site	0.633	0.367
E87.7 Fluid overload	0.633	0.367
G46 Vascular syndromes of brain in cerebrovascular diseases	0.632	0.367
G41 Status epilepticus	0.632	0.367
A48 Other bacterial diseases, not elsewhere classified	0.632	0.368
A44 Bartonellosis	0.632	0.368
A43 Nocardiosis	0.632	0.368
A42 Actinomycosis	0.632	0.368
A40 Streptococcal septicaemia	0.632	0.368
A39 Meningococcal infection	0.632	0.368
A37 Whooping cough	0.632	0.368
A36 Diphtheria	0.632	0.368
A32 Listeriosis	0.632	0.368
A31 Infection due to other mycobacteria	0.632	0.368
A30 Leprosy [Hansen's disease]	0.632	0.368
A46 Erysipelas	0.632	0.368
A38 Scarlet fever	0.632	0.368
A35 Other tetanus	0.632	0.368
A34 Obstetrical tetanus	0.632	0.368
A33 Tetanus neonatorum	0.632	0.368
J86 Pyothorax	0.631	0.368
C91 Lymphoid leukaemia	0.630	0.369
D51.8 Other vitamin B12 deficiency anaemias	0.630	0.370
D51.3 Other dietary vitamin B12 deficiency anaemia	0.630	0.370
D51.2 Transcobalamin II deficiency	0.630	0.370
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.630	0.370
E40-E46 Malnutrition	0.630	0.370
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.628	0.372
H32 Chorioretinal disorders in diseases classified elsewhere	0.627	0.372
H31 Other disorders of choroid	0.627	0.372
H30 Chorioretinal inflammation	0.627	0.372
Y79 Orthopaedic devices associated with adverse incidents	0.627	0.373
E83 Disorders of mineral metabolism	0.627	0.373
H11.9 Disorder of conjunctiva, unspecified	0.627	0.373
A41.5 Septicaemia due to other Gram-negative organisms	0.626	0.374
J32.3 Chronic sphenoidal sinusitis	0.626	0.374
J32.2 Chronic ethmoidal sinusitis	0.626	0.374
J32.1 Chronic frontal sinusitis	0.626	0.374
C68 Malignant neoplasm of other and unspecified urinary organs	0.625	0.375
C65 Malignant neoplasm of renal pelvis	0.625	0.375
N10-N16 Renal tubulo-interstitial diseases	0.624	0.376
H13 Disorders of conjunctiva in diseases classified elsewhere	0.624	0.376
N23 Unspecified renal colic	0.624	0.376
J34.2 Deviated nasal septum	0.623	0.377
B37.3 Candidiasis of vulva and vagina	0.623	0.377
J32.8 Other chronic sinusitis	0.623	0.377
B18 Chronic viral hepatitis	0.623	0.377
C67 Malignant neoplasm of bladder	0.621	0.379
G24 Dystonia	0.620	0.380
N03 Chronic nephritic syndrome	0.619	0.381
H35.3 Degeneration of macula and posterior pole	0.618	0.382
C17.9 Small intestine, unspecified	0.618	0.382
H49 Paralytic strabismus	0.611	0.389
H35.2 Other proliferative retinopathy	0.611	0.389
N32 Other disorders of bladder	0.610	0.390
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.609	0.390
G23 Other degenerative diseases of basal ganglia	0.608	0.391
G21 Secondary Parkinsonism	0.608	0.391
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.608	0.391
G22 Parkinsonism in diseases classified elsewhere	0.608	0.391
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.608	0.391
Q35-Q37 Cleft lip and cleft palate	0.608	0.391
Q30-Q34 Congenital malformations of the respiratory system	0.608	0.391
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.608	0.391
Q00-Q07 Congenital malformations of the nervous system	0.608	0.391
J39 Other diseases of upper respiratory tract	0.608	0.392
D48.5 Skin	0.608	0.392
H10 Conjunctivitis	0.608	0.392
G44 Other headache syndromes	0.607	0.393
J11 Influenza, virus not identified	0.607	0.393
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.606	0.394
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.606	0.394
Y52.4 Angiotensin-converting-enzyme inhibitors	0.606	0.394
E00-E07 Disorders of thyroid gland	0.605	0.395
G30-G32 Other degenerative diseases of the nervous system	0.605	0.395
D46.9 Myelodysplastic syndrome, unspecified	0.604	0.396
Y84.6 Urinary catheterisation	0.604	0.396
E50-E64 Other nutritional deficiencies	0.602	0.398
J37.0 Chronic laryngitis	0.602	0.398
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.602	0.398
J34.1 Cyst and mucocele of nose and nasal sinus	0.602	0.398
B25 Cytomegaloviral disease	0.601	0.399
D86 Sarcoidosis	0.601	0.399
H11.0 Pterygium	0.600	0.400
H40-H42 Glaucoma	0.600	0.400
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.599	0.400
G80-G83 Cerebral palsy and other paralytic syndromes	0.599	0.400
G45.3 Amaurosis fugax	0.598	0.401
B37.9 Candidiasis, unspecified	0.598	0.402
H11.3 Conjunctival haemorrhage	0.598	0.402
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.597	0.403
D68 Other coagulation defects	0.597	0.403
J17 Pneumonia in diseases classified elsewhere	0.596	0.404
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.596	0.404
J12 Viral pneumonia, not elsewhere classified	0.596	0.404
J10 Influenza due to identified influenza virus	0.596	0.404
J14 Pneumonia due to Haemophilus influenzae	0.596	0.404
J09 Influenza due to certain identified influenza virus	0.596	0.404
C18.5 Splenic flexure	0.595	0.405
Y48.3 Local anaesthetics	0.595	0.405
N04 Nephrotic syndrome	0.595	0.405
Y43.9 Primarily systemic agent, unspecified	0.594	0.406
Y43.8 Other primarily systemic agents, not elsewhere classified	0.594	0.406
Y43.6 Enzymes, not elsewhere classified	0.594	0.406
Y43.5 Acidifying and alkalising agents	0.594	0.406
Y43.4 Immunosuppressive agents	0.594	0.406
Y43.2 Antineoplastic natural products	0.594	0.406
Y43.0 Antiallergic and antiemetic drugs	0.594	0.406
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.593	0.407
J30.1 Allergic rhinitis due to pollen	0.593	0.407
C26.0 Intestinal tract, part unspecified	0.592	0.407
Y84.8 Other medical procedures	0.592	0.408
C50.3 Lower-inner quadrant of breast	0.591	0.409
N32.3 Diverticulum of bladder	0.591	0.409
J36 Peritonsillar abscess	0.590	0.409
J33 Nasal polyp	0.590	0.410
C50.2 Upper-inner quadrant of breast	0.589	0.411
C18.9 Colon, unspecified	0.588	0.412
H35.6 Retinal haemorrhage	0.586	0.414
G45.4 Transient global amnesia	0.586	0.414
N02 Recurrent and persistent haematuria	0.583	0.417
C90.3 Solitary plasmacytoma	0.581	0.418
C90.2 Plasmacytoma, extramedullary	0.581	0.418
C90.1 Plasma cell leukaemia	0.581	0.418
C18.8 Overlapping lesion of colon	0.581	0.418
C18.1 Appendix	0.581	0.418
H11.2 Conjunctival scars	0.581	0.418
H11.1 Conjunctival degenerations and deposits	0.581	0.418
G47.1 Disorders of excessive somnolence [hypersomnias]	0.580	0.420
C18.6 Descending colon	0.579	0.421
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.579	0.421
D48.7 Other specified sites	0.579	0.421
D48.4 Peritoneum	0.579	0.421
D48.3 Retroperitoneum	0.579	0.421
D48.2 Peripheral nerves and autonomic nervous system	0.579	0.421
D48.0 Bone and articular cartilage	0.579	0.421
N18 Chronic renal failure	0.579	0.421
J31.2 Chronic pharyngitis	0.578	0.422
J31.1 Chronic nasopharyngitis	0.578	0.422
N22 Calculus of urinary tract in diseases classified elsewhere	0.578	0.422
D02 Carcinoma in situ of middle ear and respiratory system	0.578	0.422
G25.8 Other specified extrapyramidal and movement disorders	0.577	0.423
J13 Pneumonia due to Streptococcus pneumoniae	0.577	0.423
E85 Amyloidosis	0.576	0.423
E84 Cystic fibrosis	0.576	0.423
E79 Disorders of purine and pyrimidine metabolism	0.576	0.423
E77 Disorders of glycoprotein metabolism	0.576	0.423
E76 Disorders of glycosaminoglycan metabolism	0.576	0.423
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.576	0.423
E74 Other disorders of carbohydrate metabolism	0.576	0.423
E72 Other disorders of amino-acid metabolism	0.576	0.423
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.576	0.423
E70 Disorders of aromatic amino-acid metabolism	0.576	0.423
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.576	0.423
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.576	0.424
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.576	0.424
H17 Corneal scars and opacities	0.576	0.424
H16 Keratitis	0.576	0.424
H15 Disorders of sclera	0.576	0.424
C45 Mesothelioma	0.575	0.424
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.575	0.425
G45.2 Multiple and bilateral precerebral artery syndromes	0.575	0.425
G45.1 Carotid artery syndrome (hemispheric)	0.575	0.425
G45.0 Vertebro-basilar artery syndrome	0.575	0.425
B33 Other viral diseases, not elsewhere classified	0.575	0.425
B30 Viral conjunctivitis	0.575	0.425
B27 Infectious mononucleosis	0.575	0.425
B26 Mumps	0.575	0.425
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.573	0.427
Q20-Q28 Congenital malformations of the circulatory system	0.572	0.428
G40.8 Other epilepsy	0.572	0.428
G40.7 Petit mal, unspecified, without grand mal seizures	0.572	0.428
G40.5 Special epileptic syndromes	0.572	0.428
G40.4 Other generalised epilepsy and epileptic syndromes	0.572	0.428
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.572	0.428
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.572	0.428
A49.3 Mycoplasma infection, unspecified	0.570	0.429
A49.2 Haemophilus influenzae infection, unspecified	0.570	0.429
A49.1 Streptococcal infection, unspecified	0.570	0.429
D39.1 Ovary	0.570	0.430
H26.9 Cataract, unspecified	0.570	0.430
A00-A09 Intestinal infectious diseases	0.569	0.431
N05 Unspecified nephritic syndrome	0.569	0.431
B34.9 Viral infection, unspecified	0.567	0.433
Y54.3 Benzothiadiazine derivatives	0.567	0.433
B95-B98 Bacterial, viral and other infectious agents	0.567	0.433
C50.0 Nipple and areola	0.567	0.433
N21.9 Calculus of lower urinary tract, unspecified	0.566	0.433
N21.8 Other lower urinary tract calculus	0.566	0.433
N34 Urethritis and urethral syndrome	0.566	0.434
D61 Other aplastic anaemias	0.565	0.435
Chapter XII Diseases of the skin and subcutaneous tissue	0.564	0.436
H34.8 Other retinal vascular occlusions	0.564	0.436
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.564	0.436
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.562	0.438
Y52.8 Antivaricose drugs, including sclerosing agents	0.562	0.438
Y52.7 Peripheral vasodilators	0.562	0.438
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.562	0.438
Y52.3 Coronary vasodilators, not elsewhere classified	0.562	0.438
Y52.1 Calcium-channel blockers	0.562	0.438

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations